Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory …
JS Smolen, MM Schoels, N Nishimoto… - Annals of the …, 2013 - ard.bmj.com
Background Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA)
and juvenile idiopathic arthritis (JIA), interleukin 6 (IL-6) pathway inhibition was evaluated in …
and juvenile idiopathic arthritis (JIA), interleukin 6 (IL-6) pathway inhibition was evaluated in …
[HTML][HTML] Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective
PJ Hoover, KH Costenbader - Kidney international, 2016 - Elsevier
Lupus nephritis is a common and severe manifestation of systemic lupus erythematosus that
disproportionately affects nonwhites and those in lower socioeconomic groups. This review …
disproportionately affects nonwhites and those in lower socioeconomic groups. This review …
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
S Monti, AF Águeda, RA Luqmani, F Buttgereit… - RMD open, 2019 - rmdopen.bmj.com
Objectives To analyse the current evidence for the management of large vessel vasculitis
(LVV) to inform the 2018 update of the EULAR recommendations. Methods Two systematic …
(LVV) to inform the 2018 update of the EULAR recommendations. Methods Two systematic …
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism …
S Van Assen, O Elkayam, N Agmon-Levin… - Autoimmunity …, 2011 - Elsevier
OBJECTIVES: To present the systematic literature review (SLR), which formed the basis for
the European League Against Rheumatism (EULAR) evidence-based recommendations for …
the European League Against Rheumatism (EULAR) evidence-based recommendations for …
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases
The number of individuals with autoimmune inflammatory rheumatic diseases (AIIRDs)
treated with immunosuppressive drugs is increasing steadily. The variety of …
treated with immunosuppressive drugs is increasing steadily. The variety of …
Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)
CO Bingham, W Rizzo, A Kivitz, A Hassanali… - Annals of the …, 2015 - ard.bmj.com
Objective To evaluate the effect of tocilizumab (TCZ), an interleukin 6 receptor inhibitor, on
humoral immune responses to immunisations in patients with rheumatoid arthritis (RA) …
humoral immune responses to immunisations in patients with rheumatoid arthritis (RA) …
The safety and immunologic effectiveness of the live varicella-zoster vaccine in patients receiving tumor necrosis factor inhibitor therapy: a randomized controlled trial
JR Curtis, SS Cofield, SL Bridges Jr… - Annals of internal …, 2021 - acpjournals.org
Background: The safety and effectiveness of live virus vaccines, such as the varicella-zoster
vaccine, are unknown in patients with inflammatory diseases receiving immunomodulatory …
vaccine, are unknown in patients with inflammatory diseases receiving immunomodulatory …
[HTML][HTML] Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study
L Yang, H Xie, Z Liu, Y Chen, J Wang, H Zhang, Y Ge… - BMC nephrology, 2018 - Springer
Background Severe infections are common complications of immunosuppressive treatment
for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with renal …
for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with renal …
A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis …
Background Herpes zoster (HZ) incidence is linked to immunosuppression. Patients with
psoriasis or psoriatic arthritis (PsA) on systemic therapy might be at an increased risk for HZ …
psoriasis or psoriatic arthritis (PsA) on systemic therapy might be at an increased risk for HZ …
Human papillomavirus vaccine and systemic lupus erythematosus
M Gatto, N Agmon-Levin, A Soriano, R Manna… - Clinical …, 2013 - Springer
To investigate the association between human papillomavirus (HPV) vaccination and
autoimmune manifestations compatible with systemic lupus erythematosus (SLE) or SLE …
autoimmune manifestations compatible with systemic lupus erythematosus (SLE) or SLE …